Sun Pharma shares fall to 52-week low in response to 100% US tariffs on branded, patented drugs In an interaction with CNBC-TV18 on Friday, Aditya Khemka of InCred Asset Management said that a possibility of tariffs being imposed on Pharma generics c... [2189 chars].. reed more
